683 Millennium - Seventeenth Edition SCIENCES, PHARMACEUTICALS AND BIOTECHNOLOGY facilitating various procedures and eventual drug approval. Mr. Groner initially entered the field as a research chemist at Exxon Corporate Research in 1990, after which he went on to serve as a quality assurance specialist at Warner-Lambert until 2001. He later held positions at Duramed Pharmaceuticals as an associate director of regulatory compliance and at KVD Pharma as the head of regulatory affairs and compliance until 2006. He subsequently operated in a significant leadership role as an independent consultant at Tris Pharma Inc. between 2006 and 2015. During his time as a consultant, Mr. Groner has supported multiple companies, primarily working with brand companies in the oncology sterile drugs field during the last four years. After graduating from the Rutgers Preparatory School in 1983, Mr. Groner studied chemistry at Western New England College and earned a Bachelor of Science in 1990. He expanded his professional knowledge by completing coursework toward a master’s degree in analytical chemistry at Rutgers, The State University of New Jersey. In accounting for his success, Mr. Groner credits his reliable choices as a leader. Throughout his career, he has worked diligently to develop the skills necessary to adapt to a frequently changing regulatory environment. Among his accomplishments, he is particularly proud to have pivoted toward his current role as a consultant on behalf of startup companies, through which he has eagerly seized the opportunity to utilize his expertise in regulatory affairs and quality assurance. Likewise, he finds fulfillment in serving as a mentor and ensuring that his trainees perform well in the pharmaceutical industry. Looking to the future, Mr. Groner intends to continue maintaining his career as a consultant until his eventual retirement. Recognized for more than 30 years of experience in the field of pharmaceutical regulations, W. Scott Groner has found success as the founder of Atlantic505 Consulting, a provider of pharmaceutical consulting services, since 2015. Specializing in regulatory affairs, quality assurance, and drug approval processes, Mr. Groner primarily assesses the compliance needs of his clients and works closely with them to design and execute strategic plans for W. SCOTT GRONER PHARMACEUTICAL CONSULTANT Atlantic505 Consulting Land O' Lakes, FL
RkJQdWJsaXNoZXIy MTQ5NDA2